PharmaCielo Ltd. PCLOF PCLO , the Canadian parent of Colombia's premier cultivator and producer of dried flower and medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., entered into a supply agreement with one of the largest phyto-therapeutic companies in the Brazilian market. The customer has an extensive distribution network across Latin America, and is also a certified B-Corp, reflecting its commitment to a transparent business model that measures social and environmental impacts.
PharmaCielo will be registered with Anvisa as the sole supplier to the customer for this product, and under the agreement, PharmaCielo will ship significant quarterly volumes of a proprietary CBD derivative formulation to the Customer, which will be utilized in the production of novel herbal medicines to be distributed across Latin America. The company expects to begin shipping during Q1 2023.
Management Changes
PharmaCielo has appointed Ian D. Atacan to its board of directors. Atacan has been the company's CFO since June 7, 2021.
PharmaCielo has appointed Dr. Decio Rabelo de Castro Filho as chief medical officer of the company, to advance the company's visibility within physician communities and with pharmaceutical organizations in Latin America, Europe and other key markets globally.
Dr. de Castro Filho is a medical doctor with over 20 years of experience in occupational medicine and marketing. During the course of his career, Dr. de Castro Filho has also acted as an expert medical witness for several large Brazilian companies. Dr. de Castro Filho is a graduate of the medical program at Pontifical Catholic University of Campinas and has a master's degree in Marketing from Escola Superior de Propaganda e Marketing ESPM in São Paulo. He holds a degree in cannabinoid medicine from the Wecann Academia school.
Photo: Benzinga; Sources: geralt, lindsayfox via Pixabay
Related News
PharmaCielo Ships CBD Full Spectrum Oil To A Brazilian Pharmaceutical Compan
PharmaCielo Q1 Revenue Increases 77.92% YoY, Discusses International Market
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!